Hansa Biopharma AB (publ) (STO:HNSA)
Sweden
· Delayed Price · Currency is SEK 29.48
+0.48 (1.66%)
Aug 14, 2025, 5:29 PM CET
Hansa Biopharma AB Market Cap
Hansa Biopharma AB has a market cap or net worth of 2.50 billion as of August 14, 2025. Its market cap has decreased by -11.04% in one year.
Market Cap
2.50B
Enterprise Value
3.05B
Revenue
196.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
29.48
Market Cap Chart
Since April 24, 2008, Hansa Biopharma AB's market cap has increased from 30.71M to 2.50B, an increase of 8,036.21%. That is a compound annual growth rate of 28.92%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 94.91B |
| Sectra AB | 67.02B |
| Getinge AB | 54.41B |
| Medicover AB | 41.37B |
| Asker Healthcare Group AB | 38.30B |
| Camurus AB | 37.76B |
| Bonesupport Holding AB | 20.15B |
| AddLife AB | 19.96B |